Artificial Labs

Artificial Labs, a prominent provider of digital broking and underwriting technology for the specialty and commercial insurance markets, has successfully completed a Series B funding round, raising £33 million. The investment was led by CommerzVentures, with significant support from Move Capital Fund I and existing investors.

Summary of transaction details:

• Value: £33 million
• Sector: InsurTech / Financial Technology
• Advisor: N/A
• Key Entities: Artificial Labs (Target), CommerzVentures (Lead Investor), Move Capital Fund I, Augmentum Fintech, 6 Degrees Capital, FOM, TrueSight Ventures (Investors)
• Location: UK-based company expanding globally (US market expansion mentioned).

Note: This funding is poised to significantly accelerate Artificial Labs' global growth strategy, enabling the company to double in size, expand into the US market in 2026, and further consolidate its leadership in the London insurance market. The investment will support continued innovation and team expansion to meet the increasing demand for modernized digital trading solutions in commercial and specialty insurance.